SL
Stephen L Sabba sold $545K of LGNYZ stock
Stephen L Sabba, Dir of Ligand Pharmaceuticals Inc (LGNYZ), sold 2,145 shares of LGNYZ stock worth $545K, per an SEC Form 4 filed Jun 18, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 16, 2026, 2 days before it was made public.
- Traded
- Jun 16, 2026
- Disclosed
- Jun 18, 2026
- Filing delay
- 2 days
- Role
- Dir
- Source
- SEC Form 4